Diffusion Pharmaceuticals
DFFN
#10344
Rank
HK$70 M
Marketcap
HK$34.31
Share price
10.28%
Change (1 day)
-34.22%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -HK$0.11 Billion

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -HK$0.13 Billion, an increase over its 2021 earnings that were of -HK$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -HK$0.11 Billion-15.69%
2022 -HK$0.13 Billion-36.46%
2021 -HK$0.2 Billion54.72%
2020 -HK$0.13 Billion38.32%
2019 -HK$89.42 Million-39.03%
2018 -HK$0.15 Billion677.09%
2017 -HK$18.88 Million-86.85%
2016 -HK$0.15 Billion-22.75%
2015 -HK$0.19 Billion38.74%
2014 -HK$0.14 Billion598.54%
2013 -HK$19.17 Million-57.56%
2012 -HK$45.16 Million-62.43%
2011 -HK$0.13 Billion58.75%
2010 -HK$75.73 Million238.41%
2009 -HK$22.38 Million189.55%
2008 -HK$7.73 Million1576.75%
2007 -HK$0.47 Million-35.01%
2006 -HK$0.71 Million
1999 -HK$57.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$1.16 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA